Proteomic Analysis Reveals a Metabolism Shift in a Laboratory Fluconazole-Resistant Candida albicans Strain
- 14 April 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (6) , 2248-2256
- https://doi.org/10.1021/pr060656c
Abstract
Multifactorial and multistep alterations are involved in acquired fluconazole (FLC) resistance in Candida albicans. In this study, a FLC-resistant C. albicans strain was obtained by serial cultures of a FLC-susceptible C. albicans strain in incrementally increasing concentrations of FLC. The comparative proteomic study, confirmed by real-time RT-PCR, was performed with the susceptible parental strain and the resistant daughter strain to identify proteins altered during the development of FLC resistance. Our analysis of the differentially expressed proteins identified 22 different proteins, most of which were related to energy metabolisms (e.g., Pgk1, Fba1, and Adh1), and some of which have been previously identified as being involved in FLC resistance in C. albicans (e.g., Ald5, Cdc19, and Gap1). Functional analysis revealed lower intracellular ATP level and mitochondrial membrane potential, less endogenous reactive oxygen species generation in response to antifungal agents, and identical susceptibility to exogenous hydrogen peroxide, heat, and hyperosmotic shock in the resistant strain compared with the susceptible strain. Our results suggest that a metabolism shift might contribute to FLC resistance in C. albicans. Keywords: Candida albicans • fluconazole resistance • mass spectrometry • two-dimensional polyacrylamide gel electrophoresisKeywords
This publication has 22 references indexed in Scilit:
- The concomitant expression and availability of conventional and alternative, cyanide-insensitive, respiratory pathways in Candida albicansMitochondrion, 2005
- Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003Journal of Clinical Microbiology, 2005
- Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug TransportersAntimicrobial Agents and Chemotherapy, 2004
- Activation of pleiotropic drug resistance by the J‐protein and Hsp70‐related proteins, Zuo1 and Ssz1Molecular Microbiology, 2004
- A proteomic approach to understanding the development of multidrug-resistant Candida albicans strainsMolecular Genetics and Genomics, 2004
- Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2003
- Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray AnalysisAntimicrobial Agents and Chemotherapy, 2002
- Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal EffectAntimicrobial Agents and Chemotherapy, 2002
- Evolution of Drug Resistance in Experimental Populations of Candida albicansJournal of Bacteriology, 2000
- Probability-based protein identification by searching sequence databases using mass spectrometry dataElectrophoresis, 1999